Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

‘Selling and marketing snake oil’: The debate over compounded GLP-1s

Proponents of compounding argue it increases access, lowers prices and helps patients who may need individualized versions of a drug. But there are serious concerns, experts said at the HLTH conference.

We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.

Read the original at healthcaredive.com →

More in Health & Medicine

More from Tuesday 17 November →